包装 | 价格(元) |
1mg | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
Canonical SMILES | O=C([C@@]1(CC)OC(OCC2=CC=C(NC([C@H](CCCCN)NC([C@@H](NC(COCC(NCCOCCOCCOCCOCCOCCOCCOCCOCCN3C=C(CNC(C4CCC(CN5C(C=CC5=O)=O)CC4)=O)N=N3)=O)=O)CC6=CC=CC=C6)=O)=O)C=C2)=O)OCC7=C1C=C(C8=NC9=CC=C(O)C=C9C(CC)=C8C%10)N%10C7=O.OC(C(Cl)Cl)=O |
分子式 | C82H106N12O23.XC2H2Cl2O2 |
分子量 | 1627.8 |
溶解度 | DMSO: >1mg/mL,Ethanol: >1mg/mL |
储存条件 | Store at -20°C |
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
产品描述 | CL2-SN-38 is a cleavable linker-based antibody-drug conjugate (ADC) containing the topoisomerase I inhibitor SN-38 and a maleimidocaproyl linker.1CL2-SN-38 has been linked to tumor-selective human monoclonal antibodies, such as anti-CEACAM5 (hMN-14) to target SN-38 to tumor sites and improve its solubility. CL2-SN-38 linked to hMN-14 binds (Kd= 1.4 nM) and is cytotoxic to LoVo human colon adenocarcinoma cells (IC50= 5.3 nM). CL2-SN-38 linked to hMN-14 increases survival in a colon carcinoma mouse model of lung metastasis. 1.Moon, S., Govindan, S.V., Cardillo, T.M., et al.Antibody conjugates of 7-ethyl-10-hydroxycamptothecin (SN-38) for targeted cancer chemotherapyJ. Med. Chem.51(21)6916-6926(2008) |